Trials for neurodegenerative diseases: time to innovate

Arpan R Mehta; Jeremy Chataway; Suvankar Pal; Mahesh K B Parmar; Siddharthan Chandran

doi:10.1016/S1474-4422(21)00388-4

Trials for neurodegenerative diseases: time to innovate

Arpan R Mehta, Jeremy Chataway, Suvankar Pal, Mahesh K B Parmar, Siddharthan Chandran

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	984
Journal	Lancet Neurology
Volume	20
Issue number	12
DOIs	https://doi.org/10.1016/S1474-4422(21)00388-4
Publication status	Published - 1 Dec 2021

Access to Document

10.1016/S1474-4422(21)00388-4

EMS140016Accepted author manuscript, 10.2 KBLicence: Creative Commons: Attribution (CC-BY)

Cellular And Molecular Insights Into Neurodegeneration Mediated By The C9orf72 Gene Mutation
Mehta, A., Chandran, S. & Hardingham, G.
MRC
1/08/17 → 30/01/21
Project: Research

Cite this

@article{14e30df8a3734e91957d6dc2d34322d8,

title = "Trials for neurodegenerative diseases: time to innovate",

author = "Mehta, {Arpan R} and Jeremy Chataway and Suvankar Pal and Parmar, {Mahesh K B} and Siddharthan Chandran",

year = "2021",

month = dec,

day = "1",

doi = "10.1016/S1474-4422(21)00388-4",

language = "English",

volume = "20",

pages = "984",

journal = "Lancet Neurology",

issn = "1474-4422",

publisher = "Elsevier Science",

number = "12",

}

TY - JOUR

T1 - Trials for neurodegenerative diseases

T2 - time to innovate

AU - Mehta, Arpan R

AU - Chataway, Jeremy

AU - Pal, Suvankar

AU - Parmar, Mahesh K B

AU - Chandran, Siddharthan

PY - 2021/12/1

Y1 - 2021/12/1

U2 - 10.1016/S1474-4422(21)00388-4

DO - 10.1016/S1474-4422(21)00388-4

M3 - Comment/debate

C2 - 34800413

SN - 1474-4422

VL - 20

SP - 984

JO - Lancet Neurology

JF - Lancet Neurology

IS - 12

ER -

Trials for neurodegenerative diseases: time to innovate

Access to Document

Projects

Cellular And Molecular Insights Into Neurodegeneration Mediated By The C9orf72 Gene Mutation

Cite this